Catalyst Wire Dossier Catalyst Wire Dossier

Brolucizumab

brolucizumab · Novartis
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Brolucizumab, covering 2020-08-03 to 2024-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) [Phase 4]

See pricing